NANO-METALLIC ALLOY DELIVERY SYSTEM FOR TREATMENT OF INFECTED CELLS AND LEGIONS
A system for delivering nano-metallic alloys to infected cells in a patient is disclosed. The nano-metallic alloy may be formed from binary, triple, or quadruple elemental compositions complexed in predetermined percentages of monosodium phosphate monohydrate and disodium phosphate heptahydrate. The nano-metallic alloy may be capable of eliminating infectious microorganisms within infect cells or legions without harming the cells or tissues. The system may also include a method of administering a predetermined concentration of the nano-metallic alloy in the complexing solution in the vicinity of the infected cells of legions to kill the foreign matter.
1 . A method of reducing infected cells in a patient, comprising:
administering a nano-metallic alloy formed from a base that is formed from copper complexed with Ag, Li, Zn or Mn in a monosodium phosphate monohydrate and disodium phosphate heptahydrate;
wherein the nano-metallic alloy is administered at a concentration of at least one microgram per milliliter.
2 . The method of claim 1 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one element selected from the group consisting of: Co, Ag, Zn, Li, Mn, Gd, Ho, Ce, and Sm.
3 . The method of claim 2 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one element used in concentrations between about one percent and about 99 percent.
4 . The method of claim 2 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from 20-30 percent copper and 70-80 percent of one of the group consisting of: Ag, Zn, Li and Mn.
5 . The method of claim 4 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from 30 percent copper and 70 percent of one of the group consisting of: Ag, Zn and Mn.
6 . The method of claim 1 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one alloy selected from the group consisting of: Ag—Zn, Ag—Li, Ag—Co, Ag—Ce, Ag—Ho, Ag—Sm, Ag—Mn, Zn—Co, Zn—Gd, Zn—Ho, Zn—Mn, and Zn—Ce.
7 . The method of claim 6 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy used in concentrations between about one percent and about 99 percent.
8 . The method of claim 7 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy is formed from 20-30 percent copper and 70-80 percent of one of the group consisting of Ag—Zn, Ag—Li, Ag—Co, Ag—Ce, Ag—Ho, Ag—Sm, and Ag—Mn.
9 . The method of claim 8 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from 30 percent copper and 70 percent of one of the group consisting of Ag—Zn, Ag—Li, Ag—Co, Ag—Ce, Ag—Ho, Ag—Sm, and Ag—Mn.
10 . The method of claim 9 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from Ag being 80-90 percent of one of the group consisting of the Ag—Zn, Ag—Li, Ag—Co, Ag—Ce, Ag—Ho, Ag—Sm, and Ag—Mn complex.
11 . The method of claim 6 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from Zn being 80-90 percent of the alloys having one of the following consisting of Ag, Cu, Co, Ce, Sm, Ho, Li and Mn.
12 . The method of claim 1 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one alloy selected from the group consisting of: Ag—Zn—Li, Ag—Zn—Co, Zn—Co—Ho, Zn—Co—Ce, Zn—Gd—Mn, and Zn—Co—Gd.
13 . The method of claim 12 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy used in concentrations between about one percent and about 99 percent.
14 . The method of claim 12 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy formed from 20-30 percent cooper and 70-80 percent of one of the alloys listed.
15 . The method of claim 14 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy having a ratio of Ag—Zn—Li that is about 80:10:10.
16 . The method of claim 1 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy that is less than 300 nanometers in size.
17 . The method of claim 1 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy that is between one nanometer and 100 nanometers in size.
18 . A method of reducing infected cells in a patient, comprising:
administering a nano-metallic alloy formed from a base that is formed from copper complexed with Ag, Li, Zn or Mn in a monosodium phosphate monohydrate and disodium phosphate heptahydrate;
wherein the nano-metallic alloy is administered at a concentration of at least ten micrograms per milliliter.
19 . The method of claim 18 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one element selected from the group consisting of: Co, Ag, Zn, Li, Mn, Gd, Ho, Ce, and Sm.
20 . The method of claim 18 , wherein administering the nano-metallic alloy comprises administering the nano-metallic alloy complexed with one alloy selected from the group consisting of: Ag—Zn, Ag—Li, Ag—Co, Ag—Ce, Ag—Ho, Ag—Sm, Ag—Mn, Zn—Co, Zn—Gd, Zn—Ho, Zn—Mn, and Zn—Ce.